Filing Flows

Filing Flows › Companies › SBC Medical Group Holdings › Cash flow

SBC Medical Group Holdings cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow$22.4M in Q2 2026 · $61.8M over twelve months

Operating cash flow$22.5M
Capital spending−$84K
Free cash flow+$22.4M
Cash / net income2.0×

Analysis

In Q2 2026, SBC Medical Group Holdings generated $22.5M of operating cash flow and spent $84K on capital projects, leaving free cash flow of $22.4M. That is $31.1M more than in Q2 2025 (−$8.6M).

Over the twelve months to Jun 30, 2026, operating cash flow was $62.8M; the largest uses were other investing ($41.0M), net borrowing (+) / repaid (−) ($5.1M), buybacks ($2.6M); besides operations, cash came from other financing ($35.3M), asset & business sales ($5.8M); the cash balance rose by $31.6M.

Operating cash flow was $22.5M against net income of $11.2M — 2.0× profit, cash ran ahead of reported earnings. The largest differences: income taxes payable +$11.4M, payables +$4.1M, deferred taxes −$3.5M.

Free cash flow

SBC Medical Group Holdings: free cash flow by quarterSBC Medical Group Holdings: free cash flow by quarter$4.6MQ3 2024−$7.9MQ4 2024$1.7MQ1 2025−$8.6MQ2 2025−$20.9MQ3 2025$51.2MQ4 2025$9.1MQ1 2026$22.4MQ2 2026
Operating cash flow less capital spending.
SBC Medical Group Holdings: operating cash flow against capital spendingSBC Medical Group Holdings: operating cash flow against capital spendingOperating cash flowCapital spending$5.0M$409KQ3 2024−$7.3M$590KQ4 2024$1.9M$254KQ1 2025−$8.3M$307KQ2 2025−$20.9M$43KQ3 2025$52.0M$798KQ4 2025$9.2M$125KQ1 2026$22.5M$84KQ2 2026
Latest (Q2 2026): Operating cash flow $22.5M, Capital spending $84K.

Capital allocation, year by year

SBC Medical Group Holdings: where the cash came from (up) and went (down), by fiscal yearSBC Medical Group Holdings: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedAsset salesCapital spendingBuybacksFY2023: Operating cash flow $50.7MFY2023: Net borrowing $1.0MFY2023: Shares issued $10FY2023: Asset sales $8.0MFY2023: Capital spending −$8.5M$59.7MFY2023FY2024: Operating cash flow $20.6MFY2024: Net borrowing $11.7MFY2024: Capital spending −$2.6M$32.3MFY2024FY2025: Operating cash flow $24.7MFY2025: Net borrowing −$331KFY2025: Asset sales $7.5MFY2025: Capital spending −$1.4MFY2025: Buybacks −$5.0M$32.1MFY2025
Over these 3 years operating cash flow totalled $95.9M; the largest uses were capital spending ($12.5M) and buybacks ($5.0M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$185M
Debt$37.8M
Net cash$147M
Due within a year$9.1M

SBC Medical Group Holdings funds itself: free cash flow was $61.8M over the last twelve months, and $185M of cash and investments stands against $37.8M of debt ($9.1M due within a year, 20.3× covered by cash).

SBC Medical Group Holdings: debt maturities by year (FY2025)SBC Medical Group Holdings: debt maturities by year (FY2025)$9.1MYear 1$14.0MYear 2$7.4MYear 3$6.9MYear 4$5.4MYear 5
Principal due in each year as disclosed in the annual report, against $185M of cash and investments now.

Where the cash came from and went

SBC Medical Group Holdings: sources (+) and uses (−) of cash, Q2 2026SBC Medical Group Holdings: sources (+) and uses (−) of cash, Q2 2026Operating cash flow$22.5MCash drawn (+) / kept (−)−$17.0MExchange rates−$4.1MNet borrowing (+) / repaid (−)−$2.0MOther investing$650KCapital spending−$84KOther financing$32K
SBC Medical Group Holdings: sources (+) and uses (−) of cash, TTM to Q2 2026SBC Medical Group Holdings: sources (+) and uses (−) of cash, TTM to Q2 2026Operating cash flow$62.8MOther investing−$41.0MOther financing$35.3MCash drawn (+) / kept (−)−$31.6MExchange rates−$22.5MAsset & business sales$5.8MNet borrowing (+) / repaid (−)−$5.1MBuybacks−$2.6MCapital spending−$1.0M

From profit to cash

SBC Medical Group Holdings: net income to operating cash flow, Q2 2026SBC Medical Group Holdings: net income to operating cash flow, Q2 2026Net income$11.2MDepreciation & amortization$1.1MDeferred taxes−$3.5MGains on disposals$9KInventory−$722KPayables$4.1MAccrued liabilities$1.5MContract assets$2.1MPrepaid and other assets−$119KOther liabilities$45KIncome taxes payable$11.4MOperating cash flow$22.5M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.

Every quarter

QuarterOperating cash flowCapital spendingBuybacksNet borrowing (+) / repaid (−)Cash drawn (+) / kept (−)Free cash flow
Q2 2026$22.5M−$84K—−$2.0M−$17.0M$22.4M
Q1 2026$9.2M−$125K—−$1.8M−$3.5M$9.1M
Q4 2025$52.0M−$798K—−$21K−$36.3M$51.2M
Q3 2025−$20.9M−$43K−$2.6M−$680K$25.3M−$20.9M
Q2 2025−$8.3M−$307K—−$73K−$20.7M−$8.6M
Q1 2025$1.9M−$254K—−$279K−$7.0M$1.7M
Q4 2024−$7.3M−$590K——$12.3M−$7.9M
Q3 2024$5.0M−$409K—−$30K−$33.7M$4.6M

SBC Medical Group Holdings: income statement and cash flow

SBC Medical Group Holdings, Q2 2026: revenue $49.2M (+13% year over year), operating margin 38.5%. The chart follows the revenue to costs, profit and cash.

SBC Medical Group Holdings: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.